Serum tumor markers in non-small cell lung cancer. A comparative analysis
- 1 February 1994
- Vol. 73 (3) , 605-609
- https://doi.org/10.1002/1097-0142(19940201)73:3<605::aid-cncr2820730317>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical Applications of Serum Tumor MarkersAnnals of Internal Medicine, 1991
- Frequency and Clinical Implications of Monoclonal Antibody Detection of Tumor-associated Antigens in Serum of Patients with Lung CancerAmerican Review of Respiratory Disease, 1990
- Clinical Significance of a Multiple Biomarker Assay in Patients with Lung CancerChest, 1990
- Clinical Significance of the Number of Positive Tumor Markers in Assisting the Diagnosis of Lung Cancer with Multiple Tumor Marker AssayOncology, 1990
- Monoclonal Antibody-mediated Detection of Lung Cancer Antigens in SerumAmerican Review of Respiratory Disease, 1988
- The New International Staging System for Lung CancerSurgical Clinics of North America, 1987
- Clinical value of a multiple biomarker assay in patients with bronchogenic carcinomaCancer, 1986
- Diagnostic Decision: Probability Theory in the Use of Diagnostic TestsAnnals of Internal Medicine, 1986
- Monoclonal Antibodies Specific for Two Different Histological Types of Human Lung CarcinomaHybridoma, 1984
- The value of carcinoembryonic antigen in patients with carcinoma of the lungCancer, 1979